Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 2 days ago

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 2 days ago

New blog articles detected

  • ClinicalOMICS: The Future is Fluid

    ClinicalOMICS “The Future Is Fluid” discusses the impact that liquid biopsies are having in NSCLC, and the growing promise of liquid biopsies in other tumor types. http://clinicalomics.com/articles/the-future-is-fluid/987 The post ClinicalOMICS: The Future is Fluid appeared first on Biodesix.

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 2 days ago

New blog articles detected

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 2 days ago

New blog articles detected

  • Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber

    Proteomic Test Identifies Sensitivity and Resistance to Immunotherapy in Cancer Patients   Dr. Jeffery Weber will present data from a collaboration in which proteomic tests developed by Biodesix® could help guide therapy choices in immuno-oncology. These blood-based tests, which were developed on Biodesix’s proprietary Diagnostic Cortex™ platform, may identify patients who derive significant benef...

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 1 week ago

New blog articles detected

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 1 week ago

New blog articles detected

  • CGTV: Biodesix, Bioyong, and lung cancer testing in China – watch the video

    China Television (CGTV) recently produced a story about Biodesix’s recent agreement with Bioyong to bring a version of the VeriStrat test to China. The story includes an explanation of how VeriStrat works, from Dr. Gary Pestano. https://www.youtube.com/watch?v=lSpLNHIRevc The post CGTV: Biodesix, Bioyong, and lung cancer testing in China – watch the video appeared first on Biodesix.

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 2 weeks ago

New blog articles detected

  • Biodesix® and Progenetics Announce Distribution Agreement for Israel

    March 9, 2017, Boulder, Colorado…Biodesix, Inc. (Boulder, CO, USA) and Progenetics LTD (Tel Aviv, Israel) announced today that they have entered into an international agreement where Progenetics will market and distribute kits for Biodesix’s GeneStrat® and VeriStrat® liquid biopsy tests for patients with non-small cell lung cancer (NSCLC). Both tests are now available for clinical use […] The post...

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 3 weeks ago

New blog articles detected

  • Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1

    Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1 ddPCR Assay Measures mRNA Expressions from Immune and Cancer Cell; Key Step In Development of Immunotherapy Test New data from Biodesix® evaluating an assay in development demonstrated the potential to measure circulating PD-L1 through mRNA in blood through multiplexed droplet digital™ PCR (ddPCR, Bio-Rad, Inc.) detection. The ass...

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected

  • AACR, Washington, D.C. April 1-5

    Presentation (collaboration with Streck) Title: Pre-Analytical Variable Considerations in the Development of Robust Circulating DNA and RNA ddPCR Assays   Abstract:  Successful detection of biomarkers is dependent on controlling pre-analytical variables, such as peripheral blood collection, processing, and shipment and storage methods.  Learn how Streck blood collection tubes can help preserve val...

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected

  • Biodesix to Present Study Data: Blood-Based Diagnostic Testing for PD-L1

    Biodesix to Present Study Data: Blood-Based Diagnostic Testing for PD-L1 ddPCR Test Measures mRNA Expressions from Immune and Cancer Cells   Poster Title: Development of ddPCR blood-based diagnostic tests that simultaneously measure mRNA expression from immune and cancer cells.   Poster Session Date/Time: February 24, 11:30AM – 1:00PM; 5:30PM-6:30PM   Presenting Author: Hestia Mellert, Ph.D […] Th...

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected

  • Immuno-Oncology360 February 1-3, New York, NY

    The post Immuno-Oncology360 February 1-3, New York, NY appeared first on Biodesix.

  • Clin-TOF Successfully Integrated into VeriStrat® Workflow

    Study Results, Presented at MSACL, Advance Biodesix®/Bioyong Agreement Study results presented today demonstrate the feasibility of running the VeriStrat® test on Bioyong’s Clin-TOF platform, and provide a basis for validating and deploying a version of the VeriStrat® test in Greater China. The data were presented in a poster at the ninth annual conference of the Association […] The post Clin-TOF ...

  • Patient Video: Victoria’s Story

    Video: Victoria, stage 4 lung cancer patient, discusses the impact that liquid biopsy testing had on her treatment and outlook. The post Patient Video: Victoria’s Story appeared first on Biodesix.

  • Biodesix® and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat® Test in Greater China

    US $38M; Potential Expansion into Other Asia/Pacific Countries, Additional Liquid Biopsy Products Biodesix, Inc. (Boulder, CO, USA) and Bioyong Technology Company Ltd. (Beijing, China) announced today that they have entered into an international collaboration agreement where Bioyong will develop and commercialize a version of Biodesix’s VeriStrat® proteomic blood test, a precision medicine diagnos...

  • Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy

    “VeriStrat appears to be a robust assay and should be used for EGFR wild-type patients with squamous cell lung cancer,” says study author Glenwood D. Goss, MD, professor of medicine and an oncologist in the division of medical oncology at the University of Ottawa. Biodesix presented data relating to immunotherapy selection, afatinib efficacy. The post Tests Demonstrate Ability to Stratify Patients...

  • Biodesix® Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy

    VeriStrat® Test Shown To Have Clinical Utility in Predicting Overall Survival of Afatinib-Treated Patients With Lung Cancer   December 13, 2016, Boulder, Colorado… Two studies demonstrating the clinical utility of the VeriStrat® test in the management of patients with non-small cell lung cancer (NSCLC) were presented last week at the 17th World Conference on Lung […] The post Biodesix® Tests Demon...

  • Biodesix® Named Innovative Company of the Year at 2016 IQ Awards

    Biodesix won the award for “Innovative Company of the Year” last night at the 2016 IQ Awards and Innovation Summit presented by BizWest Media. The other finalists in the category were Fort Collins-based Madwire and n.io of Broomfield. “We are really in the business of helping cancer patients to determine the most effective treatment for […] The post Biodesix® Named Innovative Company of the Year a...

  • Genestrat Liquid Biopsy Testing™ Now Includes ROS1 and RET Mutations

    Actionable mutation results from a single blood draw, 72 hour turnaround time   February 2, 2017, Boulder, CO….Biodesix®, Inc. announced today that the GeneStrat® test, a liquid biopsy for patients with cancer, now includes ROS1 and RET in addition to EGFR sensitizing; EGFR resistance (T790M), KRAS, BRAF mutations; and EML4-ALK fusions. GeneStrat is a non-invasive, […] The post Genestrat Liquid Bi...

  • 3rd Annual Moffitt Anatomic Pathology Symposium, February 2-5, Sarasota, FL

    The post 3rd Annual Moffitt Anatomic Pathology Symposium, February 2-5, Sarasota, FL appeared first on Biodesix.

  • ASCO-SITC February 23-27, Orlando, FL

    The post ASCO-SITC February 23-27, Orlando, FL appeared first on Biodesix.

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 5 months ago

New blog articles detected

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 6 months ago

Biodesix, Inc.

Category: Content
Type: Blog Article

Generated 6 months ago

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in